Literature DB >> 28742211

Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells.

Y Wang1, Y-R Zhao, A-Y Zhang, J Ma, Z-Z Wang, X Zhang.   

Abstract

The article "Targeting of miR-20a against CFLAR to potentiate TRAIL-induced apoptotic sensitivity in HepG2 cells" by Y. Wang, Y.-R. Zhao, A.-Y. Zhang, J. Ma, Z.-Z. Wang, X. Zhang, published in Eur Rev Med Pharmacol Sci 2017; 21 (9): 2087-2097 has been withdrawn.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28742211

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons.

Authors:  Jaitip Tipanee; Mario Di Matteo; Warut Tulalamba; Ermira Samara-Kuko; Jiri Keirsse; Jo A Van Ginderachter; Marinee Khim Chuah; Thierry VandenDriessche
Journal:  Mol Ther Nucleic Acids       Date:  2020-01-22       Impact factor: 8.886

2.  Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.

Authors:  Junbin Yan; Jielu Cao; Zhiyun Chen
Journal:  BMC Cancer       Date:  2021-02-18       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.